Development Of An Effective Predictive Screening Tool For Prostate Cancer Using The Claritydx Machine Learning Platform

ClarityDX is a predictive analysis platform that uses machine learning to generate risk scores for prostate cancer using biomarker data and clinical features. The platform has been used to develop a test called ClarityDX Prostate, which aims to improve the selection of men for MRI and biopsies, reducing adverse events and healthcare costs. Clinical features such as previous negative biopsies, abnormal DRE, age, PSA, and % free PSA were found to be predictive of csPCa.